In vitro susceptibility of Acinetobacter species to various antimicrobial agents
Open Access
- 1 November 1986
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 30 (5), 769-770
- https://doi.org/10.1128/aac.30.5.769
Abstract
The in vitro activity of 18 antimicrobial agents against 40 clinical isolates each of Acinetobacter calcoaceticus subsp. anitratum and Acinetobacter lwoffi was studied. Most of the newer 4-quinolone derivatives were extremely active against these organisms. Newer beta-lactam agents, such as cefpirome, BMY 28142, and BRL 36650, were also extremely active, inhibiting all strains at clinically achievable levels. Most agents were two- to fourfold more active against A. lwoffi.This publication has 8 references indexed in Scilit:
- In vitro activity of BRL 36650, a new semisynthetic penicillinAntimicrobial Agents and Chemotherapy, 1986
- In vitro activity of CI-934, a new quinolone, compared with that of other quinolones and other antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1986
- In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620Antimicrobial Agents and Chemotherapy, 1985
- Acinetobacter calcoaceticus Septicemia in Patients With CancerSouthern Medical Journal, 1985
- The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacinJournal of Antimicrobial Chemotherapy, 1985
- In vitro antibacterial properties of BRL 36650, a novel 6 alpha-substituted penicillinAntimicrobial Agents and Chemotherapy, 1984
- Antibiotics in patients with neutropenia.1984
- In vitro activities of new beta-lactam antibiotics against Acinetobacter sppAntimicrobial Agents and Chemotherapy, 1983